Lincoln Pharmaceuticals Limited (BOM:531633)

Market Cap	11.34B
Revenue (ttm)	6.23B
Net Income (ttm)	823.46M
Shares Out	20.03M
EPS (ttm)	41.11
PE Ratio	13.77
Forward PE	n/a
Dividend	1.80 (0.32%)
Ex-Dividend Date	Sep 13, 2024

Volume	977
Average Volume	3,466
Open	556.70
Previous Close	558.65
Day's Range	556.70 - 569.05
52-Week Range	500.00 - 975.00
Beta	0.31
RSI	51.77
Earnings Date	Aug 14, 2025

About Lincoln Pharmaceuticals

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It also exports its products to approximately 60 countries, including Europe, Canada, Latin and North America, Africa, the Asia Pacific, and South East As...

• Industry: Pharmaceutical Preparations
• Founded: 1979
• Employees: 1,687
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531633

Financial Performance

In 2024, Lincoln Pharmaceuticals's revenue was 6.23 billion, an increase of 7.35% compared to the previous year's 5.81 billion. Earnings were 823.46 million, a decrease of -11.74%.